These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4653992)

  • 1. Evaluation of surgery, chemotherapy and immunotherapy on Lewis lung tumour.
    Thompson RB; Alberola V; Mathé G
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):900-2. PubMed ID: 4653992
    [No Abstract]   [Full Text] [Related]  

  • 2. An experimental tumour model for the study of the effects of chemotherapy and immunotherapy in combination with surgery.
    Winsey HS; Mathé G; Thompson R
    Br J Surg; 1971 Apr; 58(4):303. PubMed ID: 5572349
    [No Abstract]   [Full Text] [Related]  

  • 3. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of Lewis lung carcinoma by combined treatment with local hyperthermia and cyclophosphamide: preliminary results.
    Yerushalmi A; Hazan G
    Isr J Med Sci; 1979 May; 15(5):462-3. PubMed ID: 447517
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of chemotherapy and immunotherapy in the treatment of carcinoma of the mammary gland in mice (author's transl)].
    Turić M; Malenica B; Rogan-Grgas J; Milas L
    Lijec Vjesn; 1978 May; 100(5):289-94. PubMed ID: 682831
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K; Rella W; Goldin A
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
    Ho W; Furst A
    Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced inhibition of tumour cell dissemination.
    Burrage K; Hellmann K; Salsbury AJ
    Br J Pharmacol; 1970 May; 39(1):205P-206P. PubMed ID: 5420103
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H; Yamaguchi Y
    Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined surgical and chemotherapeutic treatment of Lewis lung carcinoma.
    Szabó Z; Dworák O; Kopper L; Lapis K
    J Cancer Res Clin Oncol; 1980; 97(2):161-6. PubMed ID: 7462295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined treatment of Lewis lung carcinoma by tumor excision and levan.
    Leibovici J; Michowitz M; Shezen E; Wolman M; Sandbank U
    Oncology; 1981; 38(1):31-4. PubMed ID: 7443174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy, BCG, and serum from tumor-bearing mice: comparative effects on growth and spread of mouse Lewis lung cancer.
    Greager JA; Culberson G; Manning B; Das Cupta TK
    Arch Surg; 1975 Aug; 110(8):901-2. PubMed ID: 1156156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
    Poste G; Kirsh R
    Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME; Brandhorst JS; Hanna MG
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.